Phase II Study of Pembrolizumab in Combination with Carboplatin and Paclitaxel for Advanced or Recurrent Endometrial Adenocarcinoma
|Effective start/end date||12/1/17 → 11/30/22|
- BIG TEN CANCER RESEARCH CONSORTIUM
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.